CompuGroup Medical Financials
| COP Stock | 25.06 0.52 2.03% |
CompuGroup |
Understanding current and past CompuGroup Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CompuGroup Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in CompuGroup Medical's assets may result in an increase in income on the income statement.
The data published in CompuGroup Medical's official financial statements typically reflect CompuGroup Medical's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving CompuGroup Medical's quantitative information. For example, before you start analyzing numbers published by CompuGroup accountants, it’s essential to understand CompuGroup Medical's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the imprecision that can be found in CompuGroup Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CompuGroup Medical SE. Check CompuGroup Medical's Beneish M Score to see the likelihood of CompuGroup Medical's management manipulating its earnings.
| Foreign Associate | USA |
| Instrument | Germany Stock View All |
| Exchange | XETRA Stock Exchange |
| ISIN | DE000A288904 |
| Business Address | Maria Trost 21, |
| Sector | Healthcare |
| Industry | Health Information Services |
| Benchmark | NYSE Composite |
| Website | www.cgm.com |
| Phone | 49 261 8000 0 |
You should never invest in CompuGroup Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CompuGroup Stock, because this is throwing your money away. Analyzing the key information contained in CompuGroup Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CompuGroup Medical Key Financial Ratios
CompuGroup Medical's financial ratios allow both analysts and investors to convert raw data from CompuGroup Medical's financial statements into concise, actionable information that can be used to evaluate the performance of CompuGroup Medical over time and compare it to other companies across industries.| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Target Price | 57.0 | |||
| Beta | 1.07 |
CompuGroup Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CompuGroup Medical's current stock value. Our valuation model uses many indicators to compare CompuGroup Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CompuGroup Medical competition to find correlations between indicators driving CompuGroup Medical's intrinsic value. More Info.CompuGroup Medical SE is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.29 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CompuGroup Medical SE is roughly 3.49 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CompuGroup Medical's earnings, one of the primary drivers of an investment's value.CompuGroup Medical Systematic Risk
CompuGroup Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CompuGroup Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on CompuGroup Medical correlated with the market. If Beta is less than 0 CompuGroup Medical generally moves in the opposite direction as compared to the market. If CompuGroup Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CompuGroup Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CompuGroup Medical is generally in the same direction as the market. If Beta > 1 CompuGroup Medical moves generally in the same direction as, but more than the movement of the benchmark.
CompuGroup Medical Thematic Clasifications
CompuGroup Medical SE is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
CompuGroup Medical June 14, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CompuGroup Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CompuGroup Medical SE. We use our internally-developed statistical techniques to arrive at the intrinsic value of CompuGroup Medical SE based on widely used predictive technical indicators. In general, we focus on analyzing CompuGroup Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CompuGroup Medical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 15.57 | |||
| Value At Risk | (2.91) | |||
| Potential Upside | 2.83 |
Additional Tools for CompuGroup Stock Analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.